FRIEDMAN CATHY 4
4 · Lyell Immunopharma, Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
FRIEDMAN CATHY
Director
Transactions
- Award
Option (right to buy)
2024-06-14+130,000→ 130,000 totalExercise: $2.36Exp: 2034-06-13→ Common Stock (130,000 underlying)
Holdings
- 100,000(indirect: By Trust)
Common Stock
- 236,370(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The Reporting Person is a trustee of MSL FBO J DUANE & C FRIEDMAN TTEE DUANE FAMILY TRUST ("Duane Family Trust") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Family Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Family Trust except to any pecuniary interest therein.
- [F2]The Reporting Person is a trustee of The Duane Irrevocable Trust 2020 ("Duane Irrevocable Trust") and therefore may be deemed to share the power to direct the disposition and vote of the shares held by the Duane Irrevocable Trust. The Reporting Person disclaims beneficial ownership of all shares held by Duane Irrevocable Trust except to any pecuniary interest therein.
- [F3]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 14, 2024 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 14, 2024, subject to the Reporting Person providing continuous service through such date.